Other OTC - Delayed Quote USD

Guided Therapeutics, Inc. (GTHP)

0.1000 0.0000 (0.00%)
As of April 24 at 11:30 AM EDT. Market Open.

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Dr. Mark L. Faupel Ph.D. CEO, President, COO, Acting CFO, Secretary & Director 156.72k -- 1955

Guided Therapeutics, Inc.

5835 Peachtree Corners East
Suite B
Norcross, GA 30092
United States
678 329 7933 https://www.guidedinc.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
4

Description

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.

Corporate Governance

Guided Therapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 13, 2024 - May 17, 2024
Guided Therapeutics, Inc. Earnings Call

Related Tickers

QTRX Quanterix Corporation
15.78
-1.65%
 
IART Integra LifeSciences Holdings Corporation
28.13
-4.25%
 
CUTR Cutera, Inc.
1.9900
+1.53%
 
BTCY Biotricity, Inc.
1.3001
-6.47%
 
QDEL QuidelOrtho Corporation
39.24
-3.88%
 
CATX Perspective Therapeutics, Inc.
1.6500
-2.38%
 
ASXC Asensus Surgical, Inc.
0.2410
-0.82%
 
SINT Sintx Technologies, Inc.
0.0370
-4.40%